富营养饮食重塑代谢性疾病易感猪关键组织mRNA剪接模式研究

doi:10.11843/j.issn.0366-6964.2022.08.012

摘要/Abstract

摘要： 旨在探讨富营养饮食对代谢性疾病易感猪关键组织可变剪接（alternative splicing，AS）和剪接因子（splicing factors，SFs）的影响。本研究以健康状态、月龄和体重相同的12头代谢性疾病易感公猪为材料，随机将其分为两组，其中8头猪饲喂高脂高能量饲料2个月作为富营养饮食组（TG-HFHSD），4头猪饲喂正常饲料2个月作为对照饮食组（TG-CD）。对TG-HFHSD和TG-CD的脂肪、肝、肌肉和下丘脑组织进行RNA-seq测序，利用rMATS软件鉴定组间差异AS，对差异剪接基因（differential splicing genes，DSGs）进行GO和KEGG富集分析，并利用DESeq2软件和皮尔逊相关性系数分析肝组织中的SFs。结果显示，脂肪、肝、肌肉和下丘脑中分别鉴定到48 279、39 536、47 888和52 210个AS事件，均以SE类型为主，占比在77.09%～78.29%之间。脂肪、肝、肌肉和下丘脑中的DSGs数分别为528、1 070、570和600个，其中肝增加的DSGs部分主要是RI和MXE两种类型，分别为177和471个，而其它组织仅为12～28个和99～110个。GO和KEGG富集显示，肝DSGs除富集到细胞结构相关的过程外，还显著富集到可变剪接及mRNA代谢、脂质代谢、DNA损伤及修复、补体与凝血级联等过程。肝中筛选到56个差异表达的SFs，其中CLK1、PGC-1ɑ、USP4等与糖脂代谢和代谢性疾病密切相关。本研究表明，富营养饮食显著增加了肝DSGs，通过剪接调控、糖脂代谢以及DNA损伤来影响肝代谢性疾病的发生，将为肝代谢性疾病早期发生机制研究提供参考。

关键词: 富营养饮食, 代谢性脂肪肝病, 代谢性疾病易感猪, 可变剪接, 剪接因子

Abstract: The objective of this study was to investigate the effects of nutritious diet on alternative splicing (AS) and splicing factors (SFs) in key tissues of metabolic disease susceptible pigs. Twelve metabolic disease susceptible male pigs with the same health status, age and body weight were randomly divided into 2 groups. Eight pigs were fed a high fat and energy diet for 2 months as the nutrient-rich diet group (TG-HFHSD), and 4 pigs were fed a normal diet for 2 months as the control diet group (TG-CD).The adipose, liver, muscle, and hypothalamus tissues of TG-HFHSD and TG-CD were sequenced by RNA-seq, and the differential AS between the groups was identified by rMATS software, GO and KEGG enrichment analysis of differential splicing genes (DSGs), and SFs in liver was analyzed by DESeq2 software and pearson correlation coefficient. The results showed that 48 279, 39 536, 47 888 and 52 210 AS events were identified in adipose, liver, muscle, and hypothalamus, respectively, all of which were mainly of SE type, accounting for 77.09%-78.29%. The number of DSGs in adipose, liver, muscle, and hypothalamus were 528, 1 070, 570, and 600, respectively. The increased DSGs in the liver mainly came from RI and MXE with 177 and 471, respectively, while only 12-28 and 99-110 for other tissues. The enrichment of GO and KEGG showed that, in addition to the processes related to cell structure, the DSGs in liver was also significantly enriched in processes such as alternative splicing and mRNA metabolism, lipid metabolism, DNA damage and repair, complement and coagulation cascades. Fifty-six differentially expressed SFs were screened from liver, among which CLK1, PGC-1ɑ, USP4 and others were closely related to glucolipid metabolism and metabolic diseases. The results of this study showed that nutritious diet significantly increased DSGs in liver and affected the occurrence of liver metabolic diseases through splicing regulation, glucolipid metabolism and DNA damage, which will provide reference for the study of the early pathogenesis of liver metabolic diseases.

Key words: nutritious diet, metabolic fatty liver disease, metabolic disease-susceptible pigs, alternative splicing, splicing factor

中图分类号:

R589.9

夏博策, 张凯艺, 苗佳坤, 彭焕祺, 杨宇, 陶聪, 吴添文, 王彦芳, 杨述林. 富营养饮食重塑代谢性疾病易感猪关键组织mRNA剪接模式研究[J]. 畜牧兽医学报, 2022, 53(8): 2537-2547.

XIA Boce, ZHANG Kaiyi, MIAO Jiakun, PENG Huanqi, YANG Yu, TAO Cong, WU Tianwen, WANG Yanfang, YANG Shulin. Study on the mRNA Splicing Pattern Reshaped by the Nutritious Diet in Key Tissues of Metabolic Disease Susceptible Pigs[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(8): 2537-2547.

参考文献 47

[1]	LIN X H, LI H.Obesity:epidemiology, pathophysiology, and therapeutics[J].Front Endocrinol, 2021, 12:706978.
[2]	KLEINERT M, CLEMMENSEN C, HOFMANN S M, et al.Animal models of obesity and diabetes mellitus[J].Nat Rev Endocrinol, 2018, 14(3):140-162.
[3]	XU Y T, CURTASU M V, BACH KNUDSEN K E, et al.Dietary fibre and protein do not synergistically influence insulin, metabolic or inflammatory biomarkers in young obese G ttingen minipigs[J]. Br J Nutr, 2021, 125(7):828-840.
[4]	CURTASU M V, SKOU HEDEMANN M, NYGAARD LÆRKE H, et al.Obesity development and signs of metabolic abnormalities in young G ttingen minipigs consuming energy dense diets varying in carbohydrate quality[J].Nutrients, 2021, 13(5):1560.
[5]	ZHANG X, LERMAN L O.Investigating the metabolic syndrome:contributions of swine models[J].Toxicol Pathol, 2016, 44(3):358-366.
[6]	GRAVELEY B R.Alternative splicing:increasing diversity in the proteomic world[J].Trends Genet, 2001, 17(2):100-107.
[7]	疏泽, 王立贤, 王立刚.可变剪接及其在畜禽育种中的研究与应用[J].畜牧兽医学报, 2020, 51(12):2911-2920.SHU Z, WANG L X, WANG L G.Research progress of alternative splicing and its application in livestock and poultry breeding[J].Acta Veterinaria et Zootechnica Sinica, 2020, 51(12):2911-2920.(in Chinese)
[8]	BARALLE M, BARALLE F E.Alternative splicing and liver disease[J].Ann Hepatol, 2021, 26:100534.
[9]	WU P, ZHANG M Y, WEBSTER N J G.Alternative RNA splicing in fatty liver disease[J].Front Endocrinol, 2021, 12:613213.
[10]	DLAMINI Z, HULL R, MAKHAFOLA T J, et al.Regulation of alternative splicing in obesity-induced hypertension[J].Diabetes Metab Syndr Obes, 2019, 12:1597-1615.
[11]	WONG C M, XU L, YAU M Y C.Alternative mRNA splicing in the pathogenesis of obesity[J].Int J Mol Sci, 2018, 19(2):632.
[12]	LAUSTRIAT D, GIDE J, BARRAULT L, et al.In vitro and in vivo modulation of alternative splicing by the biguanide metformin[J].Mol Ther Nucleic Acids, 2015, 4(11):e262.
[13]	SANTO J, LOPEZ-HERRERA C, APOLIT C, et al.Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice[J].Int J Obes, 2017, 41(3):390-401.
[14]	KAMINSKA D, PIHLAJAMAKI J.Regulation of alternative splicing in obesity and weight loss[J].Adipocyte, 2013, 2(3):143-147.
[15]	ZHANG K Y, TAO C, XU J P, et al.CD8+ T cells involved in metabolic inflammation in visceral adipose tissue and liver of transgenic pigs[J].Front Immunol, 2021, 12:690069.
[16]	WEBSTER N J G.Alternative RNA splicing in the pathogenesis of liver disease[J].Front Endocrinol, 2017, 8:133.
[17]	CARPENTER S, RICCI E P, MERCIER B C, et al.Post-transcriptional regulation of gene expression in innate immunity[J].Nat Rev Immunol, 2014, 14(6):361-376.
[18]	ZHANG Y, XUE L Y, XU H, et al.Global analysis of alternative splicing difference in peripheral immune organs between tongcheng pigs and large white pigs artificially infected with PRRSV in vivo[J].Biomed Res Int, 2020, 2020:4045204.
[19]	张敏, 王杰, 孙艳发, 等.肉鸡肌肉与脂肪组织基因组差异剪接基因分析[J].畜牧兽医学报, 2018, 49(10):2124-2132.ZHANG M, WANG J, SUN Y F, et al.Differential splicing gene analysis between muscle and fat tissues in broilers[J].Acta Veterinaria et Zootechnica Sinica, 2018, 49(10):2124-2132.(in Chinese)
[20]	冉茂良, 陈斌, 李智, 等.基于RNA-seq测序数据鉴定和分析猪基因组可变剪接事件[J].中国科学:生命科学, 2016, 46(3):274-284.RAN M L, CHEN B, LI Z, et al.Identification and analysis of alternative splicing events in Sus scrofa using RNA-seq data[J].Scientia Sinica Vitae, 2016, 46(3):274-284.(in Chinese)
[21]	CIOFFI F, SENESE R, LASALA P, et al.Fructose-rich diet affects mitochondrial DNA damage and repair in rats[J].Nutrients, 2017, 9(4):323.
[22]	CAMBINDOBOTTO A E, MUÑOZ J C, GIONO L E, et al.Reciprocal regulation between alternative splicing and the DNA damage response[J].Genet Mol Biol, 2020, 43(1 suppl.1):e20190111.
[23]	GARCÍA-MORENO J F, ROM ÃO L.Perspective in alternative splicing coupled to nonsense-mediated mRNA decay[J].Int J Mol Sci, 2020, 21(24):9424.
[24]	CONWAY E M.Complement-coagulation connections[J].Blood Coagul Fibrinolysis, 2018, 29(3):243-251.
[25]	SHEN C H, TUNG S Y, HUANG W S, et al.Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach[J].Toxicology, 2014, 316:61-70.
[26]	DHARURI H, 'THOEN P A C, VAN KLINKEN J B, et al.Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss[J].Diabetologia, 2014, 57(11):2384-2392.
[27]	GU L, ZHU Y H, LIN X, et al.Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis[J].Oncogene, 2020, 39(11):2437-2449.
[28]	VLUGGENS A, ANDREOLETTI P, VISWAKARMA N, et al.Functional significance of the two ACOX1 isoforms and their crosstalks with PPARα and RXRα[J].Lab Invest, 2010, 90(5):696-708.
[29]	WANG J J, ZHANG Y T, TSENG Y J, et al.miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes[J].Hepatobiliary Pancreat Dis Int, 2019, 18(4):360-365.
[30]	MOYLAN C A, PANG H, DELLINGER A, et al.Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease[J].Hepatology, 2014, 59(2):471-482.
[31]	HUANG X L, LIU J G, MO X W, et al.Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer[J].Aging, 2019, 11(19):8270-8293.
[32]	ZHANG L, YANG H C, ZHANG W B, et al.Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance[J].J Neurochem, 2017, 142(4):574-588.
[33]	UZOR S, ZORZOU P, BOWLER E, et al.Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention[J].Gene, 2018, 670:46-54.
[34]	KIM M J, YU C Y, THEUSCH E, et al.SUGP1 is a novel regulator of cholesterol metabolism[J].Hum Mol Genet, 2016, 25(14):3106-3116.
[35]	NOH J H, KIM K M, IDDA M L, et al.GRSF1 suppresses cell senescence[J].Aging, 2018, 10(8):1856-1866.
[36]	NOH J H, KIM K M, PANDEY P R, et al.Loss of RNA-binding protein GRSF1 activates mTOR to elicit a proinflammatory transcriptional program[J].Nucleic Acids Res, 2019, 47(5):2472-2486.
[37]	AZEVEDO FOINQUINOS G, AZEVEDO ACIOLI M E, SANTANA CAVALCANTI A H, et al.Influence of LGALS3 and PNPLA3 genes in non-alcoholic steatohepatitis (NASH) in patients undergone bariatric surgery[J].Obes Res Clin Pract, 2020, 14(4):326-332.
[38]	AUNG L H H, YIN R X, WU D F, et al.Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia[J].J Cell Mol Med, 2014, 18(7):1417-1428.
[39]	LIN E, KUO P H, LIU Y L, et al.Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population[J].Sci Rep, 2016, 6:36830.
[40]	ZHANG L L, YOU Y Y, WU Y H, et al.Association of BUD13 polymorphisms with metabolic syndrome in Chinese population:a case-control study[J].Lipids Health Dis, 2017, 16(1):127.
[41]	BHATE A, PARKER D J, BEBEE T W, et al.ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation[J].Nat Commun, 2015, 6:8768.
[42]	HYUN J, SUN Z L, AHMADI A R, et al.Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis[J].J Clin Invest, 2020, 130(4):2129-2145.
[43]	KOBAYASHI M, DEGUCHI Y, NOZAKI Y, et al.Contribution of PGC-1α to obesity- and caloric restriction-related physiological changes in white adipose tissue[J].Int J Mol Sci, 2021, 22(11):6025.
[44]	ZHANG R N, SHEN F, PAN Q, et al.PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease[J].World J Gastroenterol, 2021, 27(25):3863-3876.
[45]	WANG Q L, ZHAO B, ZHANG J, et al.Faster lipid β-oxidation rate by acetyl-CoA carboxylase 2 inhibition alleviates high-glucose-induced insulin resistance via SIRT1/PGC-1α in human podocytes[J].J Biochem Mol Toxicol, 2021, 35(7):e22797.
[46]	TAUER J T, BORASCHI-DIAZ I, AL RIFAI O, et al.Male but not female mice with severe osteogenesis imperfecta are partially protected from high-fat diet-induced obesity[J].Mol Genet Metab, 2021, 133(2):211-221.
[47]	ZHAO Y C, WANG F, GAO L C, et al.Ubiquitin-specific protease 4 is an endogenous negative regulator of metabolic dysfunctions in nonalcoholic fatty liver disease in mice[J].Hepatology, 2018, 68(3):897-917.